文献速递认知障碍与痴呆

社区成人不可改变风险因素与阿尔茨海默病血液生物标志物的关联:ESTHER研究

Association of Nonmodifiable Risk Factors With Alzheimer Disease Blood Biomarkers in Community-Dwelling Adults in the ESTHER Study.
PubMed 文献 · Neurology · 2025-04-16

基于德国ESTHER队列(n=9,940)的巢式病例对照研究(1,026人,基线50-75岁,随访17年)发现,P-tau181与年龄和APOEe4相关,NfL与年龄和性别相关,GFAP与年龄、性别、APOEe4和绝经状态相关;女性GFAP水平及升高速度更高,尤其是绝经前参与者。

要点

  • 年龄与所有痴呆相关血液标志物横断面和纵向显著相关(p<0.001)。
  • APOEe4与P-tau181和GFAP基线和纵向水平显著相关(p<0.05)。
  • 女性GFAP水平及升高速度更高(p<0.001),绝经前状态与更高GFAP水平相关(β=19.09, p<0.05)。

核心结论

  • P-tau181依赖年龄和APOEe4;NfL依赖年龄和性别;GFAP依赖年龄、性别、APOEe4和绝经状态。
  • 女性GFAP水平及升高速度更高,尤其是绝经前参与者。

研究设计与样本

  • 德国ESTHER人群队列(n=9,940)中的巢式病例对照研究,纳入1,026名基线50-75岁参与者(1:1匹配,随访期间无痴呆 vs 发生痴呆),随访17年。
  • 血液生物标志物(P-tau181、NfL、GFAP)在基线、8年和11年随访时测量,采用横断面和纵向回归分析。

主要发现

  • 年龄与所有痴呆相关标志物横断面和纵向显著相关(p<0.001)。
  • 基线时NfL和GFAP与年龄的Spearman相关系数分别为0.55和0.49,高于P-tau181的0.21。
  • 女性GFAP水平和升高速度显著更高(p<0.001);男性调整年龄和APOEe4后NfL水平更高(p<0.01)。
  • APOEe4与P-tau181基线水平(β=0.30, p<0.05)和GFAP基线水平(β=15.84, p<0.001)显著相关。
  • 调整年龄、性别和APOEe4后,绝经前状态与更高GFAP水平显著相关(β=19.09, p<0.05)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Dementia-related blood biomarkers are the future of large-scale dementia risk stratification; however, the extent to which phosphorylated tau (P-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) are associated with nonmodifiable risk factors has yet to be confirmed in the community, and the role of menopause has yet to be investigated. Therefore, the aim of this study was to examine the association of age, sex, APOEe4 status, and menopause, with dementia-related blood biomarker levels (P-tau181, NfL, and GFAP) and rate of change over 11 years in longitudinal biomarker measurements in community-dwelling adults. METHODS: Within this German population-based Epidemiologische Studie zu Chancen der Verhütung, Früherkennung und optimierten Therapie chronischer Erkrankungen in der älteren Bevölkerung cohort study (n = 9,940), a nested case-control study of 1,026 participants (1:1, without dementia during follow-up: incident dementia during follow-up) aged 50-75 years at baseline followed over 17 years was conducted. Blood biomarker measurements (P-tau181, NfL, and GFAP) were completed in blood from baseline, 8-year, and 11-year follow-ups, and cross-sectional and longitudinal regression analyses were used to assess the association with age, sex, APOEe4, and menopause. RESULTS: The mean age of participants was 64 years, and women accounted for slightly over half (54%) of the sample. Age was cross-sectionally and longitudinally significantly associated with all dementia-related biomarkers (p < 0.001). NfL and GFAP levels more strongly correlated (Spearman R = 0.55 and 0.49) with age at baseline than P-tau181 levels (Spearman R = 0.21). Women experienced significantly higher levels and rates of increase in GFAP (p < 0.001) while men experienced higher levels of NfL after adjusting for age and APOEe4 (p < 0.01). APOEe4 status was significantly associated with baseline and longitudinal levels of P-tau181 (baseline β = 0.30, p < 0.05) and GFAP (baseline β = 15.84, p < 0.001). Of interest, premenopausal status was significantly associated with higher GFAP levels after adjusting for age, sex, and APOEe4 (β = 19.09, p < 0.05). DISCUSSION: This population-based study on dementia biomarkers found that P-tau181 was dependent on age and APOEe4; NfL on age and sex; and GFAP on age, sex, APOEe4, and menopause status. GFAP levels and rate of increase were higher in women, especially in premenopausal participants. Future research should confirm these findings and further explore the role of menopause in dementia pathogenesis among women.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Stocker H, Beyer L, Trares K, et al. Association of Nonmodifiable Risk Factors With Alzheimer Disease Blood Biomarkers in Community-Dwelling Adults in the ESTHER Study. Neurology. 2025. PMID: 40239154. doi:10.1212/WNL.0000000000213500

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。